(Q46527475)

22 December 2017

title

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification (English)

1 reference

22 December 2017

2

Roger Pique-Regi

0 references

Robert C Seeger

10

object named as

Robert C Seeger

1 reference

22 December 2017

Katherine K Matthay

7

object named as

Katherine Matthay

1 reference

22 December 2017

author name string

Shahab Asgharzadeh

1

1 reference

22 December 2017

Richard Sposto

3

1 reference

22 December 2017

Hong Wang

4

1 reference

22 December 2017

Yujun Yang

5

1 reference

22 December 2017

Hiroyuki Shimada

6

1 reference

22 December 2017

Jonathan Buckley

8

1 reference

22 December 2017

Antonio Ortega

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

22 December 2017

Journal of the National Cancer Institute

published in

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

17

1 reference

22 December 2017

page(s)

1193-1203

1 reference

22 December 2017

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Molecular biology of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression and function of TRK-B and BDNF in human neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Clinical trial designs for predictive marker validation in cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ330

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ330

1 reference

22 December 2017

1 reference

22 December 2017